XML 16 R3.htm IDEA: XBRL DOCUMENT v3.20.4
Condensed Consolidated Balance Sheets (Parenthetical) - USD ($)
$ in Thousands
Dec. 31, 2020
Dec. 31, 2019
Deferred financing costs $ 12,993 $ 17,190
Deferred financing costs $ 20,100 $ 24,500
Preferred stock, par value (in dollars per share) $ 0.01 $ 0.01
Preferred stock, shares authorized (in shares) 50,000,000 50,000,000
Preferred stock, shares issued (in shares) 6,770,393 6,770,393
Preferred stock, shares outstanding (in shares) 6,770,393 6,770,393
Preferred stock, liquidation preference $ 169,260 $ 169,260
Common stock, par value (in dollars per share) $ 0.01 $ 0.01
Common stock, shares authorized (in shares) 450,000,000 450,000,000
Common stock, shares issued (in shares) 139,295,867 153,537,296
Common stock, shares outstanding (in shares) 139,295,867 153,537,296
CECL allowance $ 213,102 $ 38,102
Loan specific reserves 175,000 56,981
General CECL allowance related to unfunded commitments 3,365 0
Secured Debt    
Deferred financing costs 7,130 7,277
Commercial Mortgage Portfolio Segment    
Loans pledged as collateral $ 5,418,999 $ 4,852,087